Castle Biosciences (CSTL) Cash from Investing Activities Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | -8.06% |
| 10 | Castle Biosciences | 917.75 Mn | 650.93 Mn | 79.85 Mn | 43.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.75% |
| Mar 31, 2026 | -15.03% |
| Dec 31, 2025 | 53.05% |
| Sep 30, 2025 | -24.34% |
| Jun 30, 2025 | -32.50% |
| Mar 31, 2025 | -13.86% |
| Dec 31, 2024 | 175.21% |
| Sep 30, 2024 | -52.34% |
| Jun 30, 2024 | -39.19% |
| Mar 31, 2024 | -218.80% |
| Dec 31, 2023 | -71.17% |
| Sep 30, 2023 | 92.76% |
| Jun 30, 2023 | 44.07% |
| Mar 31, 2023 | 4,225.37% |
| Dec 31, 2022 | 85.49% |
| Sep 30, 2022 | -14,434.13% |
| Jun 30, 2022 | 19.31% |
| Mar 31, 2022 | 46.40% |
| Dec 31, 2021 | -5,153.23% |
| Sep 30, 2021 | 51.52% |